GSA Capital Partners’s Flexion Therapeutics, Inc. FLXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-55,504
| Closed | -$497K | – | 1726 |
|
|
2021
Q1 | $497K | Buy |
+55,504
| New | +$497K | 0.08% | 356 |
|
|
2020
Q2 | – | Sell |
-24,603
| Closed | -$194K | – | 1289 |
|
|
2020
Q1 | $194K | Buy |
+24,603
| New | +$194K | 0.05% | 766 |
|
|
2019
Q4 | – | Sell |
-18,951
| Closed | -$260K | – | 1845 |
|
|
2019
Q3 | $260K | Buy |
18,951
+477
| +3% | +$6.54K | 0.04% | 1030 |
|
|
2019
Q2 | $227K | Buy |
18,474
+7,334
| +66% | +$90.1K | 0.03% | 1174 |
|
|
2019
Q1 | $139K | Buy |
+11,140
| New | +$139K | 0.01% | 1295 |
|
|
2018
Q1 | – | Sell |
-68,900
| Closed | -$1.73M | – | 1903 |
|
|
2017
Q4 | $1.73M | Buy |
68,900
+32,800
| +91% | +$821K | 0.11% | 298 |
|
|
2017
Q3 | $873K | Sell |
36,100
-25,400
| -41% | -$614K | 0.06% | 608 |
|
|
2017
Q2 | $1.24M | Buy |
+61,500
| New | +$1.24M | 0.08% | 396 |
|